ZCM
CSII

Zebra Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Zebra Capital Management’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,849
Closed -$225K – 179
2021
Q3 		$225K Sell
6,849
-1,609
-19% -$60K 0.27% 138
2021
Q2 		$361K Sell
8,458
-913
-10% -$35.7K 0.42% 90
2021
Q1 		$359K Sell
9,371
-5,038
-35% -$214K 0.4% 93
2020
Q4 		$631K Sell
14,409
-857
-6% -$32.2K 0.8% 45
2020
Q3 		$601K Buy
+15,266
New +$493K 0.93% 28

Other funds holding CSII

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Zebra Capital Management's CSII Position: Q4 2021 in Review

Zebra Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2021, closing a stake of 6,849 shares — an estimated $225K sold.

Zebra Capital Management first reported a position in CSII in Q3 2020 and held it in 5 quarters. The position peaked at $631K in Q4 2020. 167 funds tracked by Wall St. Rank hold CSII as of Q4 2021.

  • Zebra Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q4 2021 after selling out during the quarter.
  • Zebra Capital Management sold 6,849 Cardiovascular Systems, Inc. shares in Q4 2021, an estimated $225K.
  • Zebra Capital Management first reported a position in Cardiovascular Systems, Inc. in Q3 2020 and held it in 5 quarters.
  • Zebra Capital Management's Cardiovascular Systems, Inc. position peaked at $631K in Q4 2020.
  • 167 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2021.

Based on Zebra Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.